-
Something wrong with this record ?
Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers
P. Garces, CA. Antoniades, A. Sobanska, N. Kovacs, SH. Ying, AS. Gupta, S. Perlman, DJ. Szmulewicz, C. Pane, AH. Németh, LB. Jardim, G. Coarelli, M. Dankova, A. Traschütz, AA. Tarnutzer
Language English Country United States
Document type Systematic Review, Journal Article
NLK
ProQuest Central
from 2002-03-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2002-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 2002-03-01 to 1 year ago
Health & Medicine (ProQuest)
from 2002-03-01 to 1 year ago
- MeSH
- Biomarkers MeSH
- Consensus * MeSH
- Humans MeSH
- Eye Movements physiology MeSH
- Ocular Motility Disorders diagnosis physiopathology genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Systematic Review MeSH
Oculomotor deficits are common in hereditary ataxia, but disproportionally neglected in clinical ataxia scales and as outcome measures for interventional trials. Quantitative assessment of oculomotor function has become increasingly available and thus applicable in multicenter trials and offers the opportunity to capture severity and progression of oculomotor impairment in a sensitive and reliable manner. In this consensus paper of the Ataxia Global Initiative Working Group On Digital Oculomotor Biomarkers, based on a systematic literature review, we propose harmonized methodology and measurement parameters for the quantitative assessment of oculomotor function in natural-history studies and clinical trials in hereditary ataxia. MEDLINE was searched for articles reporting on oculomotor/vestibular properties in ataxia patients and a study-tailored quality-assessment was performed. One-hundred-and-seventeen articles reporting on subjects with genetically confirmed (n=1134) or suspected hereditary ataxia (n=198), and degenerative ataxias with sporadic presentation (n=480) were included and subject to data extraction. Based on robust discrimination from controls, correlation with disease-severity, sensitivity to change, and feasibility in international multicenter settings as prerequisite for clinical trials, we prioritize a core-set of five eye-movement types: (i) pursuit eye movements, (ii) saccadic eye movements, (iii) fixation, (iv) eccentric gaze holding, and (v) rotational vestibulo-ocular reflex. We provide detailed guidelines for their acquisition, and recommendations on the quantitative parameters to extract. Limitations include low study quality, heterogeneity in patient populations, and lack of longitudinal studies. Standardization of quantitative oculomotor assessments will facilitate their implementation, interpretation, and validation in clinical trials, and ultimately advance our understanding of the evolution of oculomotor network dysfunction in hereditary ataxias.
Departamento de Medicina Interna Universidade Federal do Rio Grande do Sul Porto Alegre Brazil
Department of Neurology Massachusetts General Hospital Harvard Medical School Boston MA USA
Department of Neurology University of Pécs Medical School Pécs Hungary
Faculty of Medicine University of Zurich Zurich Switzerland
German Center for Neurodegenerative Diseases University of Tübingen Tübingen Germany
Institute of Psychiatry and Neurology Warsaw Poland
Neurology Cantonal Hospital of Baden 5404 Baden Switzerland
Nuffield Department of Clinical Neurosciences University of Oxford Oxford UK
Oxford Centre for Genomic Medicine Oxford University Hospitals NHS Trust Oxford UK
The Florey Institute of Neuroscience and Mental Health Parkville Melbourne VIC 3052 Australia
University of California Los Angeles Los Angeles California USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013826
- 003
- CZ-PrNML
- 005
- 20240905133904.0
- 007
- ta
- 008
- 240725s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12311-023-01559-9 $2 doi
- 035 __
- $a (PubMed)37117990
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Garces, Pilar $u Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland
- 245 10
- $a Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers / $c P. Garces, CA. Antoniades, A. Sobanska, N. Kovacs, SH. Ying, AS. Gupta, S. Perlman, DJ. Szmulewicz, C. Pane, AH. Németh, LB. Jardim, G. Coarelli, M. Dankova, A. Traschütz, AA. Tarnutzer
- 520 9_
- $a Oculomotor deficits are common in hereditary ataxia, but disproportionally neglected in clinical ataxia scales and as outcome measures for interventional trials. Quantitative assessment of oculomotor function has become increasingly available and thus applicable in multicenter trials and offers the opportunity to capture severity and progression of oculomotor impairment in a sensitive and reliable manner. In this consensus paper of the Ataxia Global Initiative Working Group On Digital Oculomotor Biomarkers, based on a systematic literature review, we propose harmonized methodology and measurement parameters for the quantitative assessment of oculomotor function in natural-history studies and clinical trials in hereditary ataxia. MEDLINE was searched for articles reporting on oculomotor/vestibular properties in ataxia patients and a study-tailored quality-assessment was performed. One-hundred-and-seventeen articles reporting on subjects with genetically confirmed (n=1134) or suspected hereditary ataxia (n=198), and degenerative ataxias with sporadic presentation (n=480) were included and subject to data extraction. Based on robust discrimination from controls, correlation with disease-severity, sensitivity to change, and feasibility in international multicenter settings as prerequisite for clinical trials, we prioritize a core-set of five eye-movement types: (i) pursuit eye movements, (ii) saccadic eye movements, (iii) fixation, (iv) eccentric gaze holding, and (v) rotational vestibulo-ocular reflex. We provide detailed guidelines for their acquisition, and recommendations on the quantitative parameters to extract. Limitations include low study quality, heterogeneity in patient populations, and lack of longitudinal studies. Standardization of quantitative oculomotor assessments will facilitate their implementation, interpretation, and validation in clinical trials, and ultimately advance our understanding of the evolution of oculomotor network dysfunction in hereditary ataxias.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a konsensus $7 D032921
- 650 _2
- $a poruchy hybnosti oka $x diagnóza $x patofyziologie $x genetika $7 D015835
- 650 _2
- $a pohyby očí $x fyziologie $7 D005133
- 650 _2
- $a biologické markery $7 D015415
- 655 _2
- $a systematický přehled $7 D000078182
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Antoniades, Chrystalina A $u NeuroMetrology Lab, Nuffield Department of Clinical Neurosciences, Clinical Neurology, Medical Sciences Division, University of Oxford, Oxford, OX3 9DU, UK
- 700 1_
- $a Sobanska, Anna $u Institute of Psychiatry and Neurology, Warsaw, Poland
- 700 1_
- $a Kovacs, Norbert $u Department of Neurology, University of Pécs, Medical School, Pécs, Hungary
- 700 1_
- $a Ying, Sarah H $u Department of Otology and Laryngology and Department of Neurology, Harvard Medical School, Boston, MA, USA
- 700 1_
- $a Gupta, Anoopum S $u Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- 700 1_
- $a Perlman, Susan $u University of California Los Angeles, Los Angeles, California, USA
- 700 1_
- $a Szmulewicz, David J $u Balance Disorders and Ataxia Service, Royal Victoria Eye and Ear Hospital, East Melbourne, Melbourne, VIC, 3002, Australia $u The Florey Institute of Neuroscience and Mental Health, Parkville, Melbourne, VIC, 3052, Australia
- 700 1_
- $a Pane, Chiara $u Department of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples "Federico II", Naples, Italy
- 700 1_
- $a Németh, Andrea H $u Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK $u Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, UK
- 700 1_
- $a Jardim, Laura B $u Departamento de Medicina Interna, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil $u Serviço de Genética Médica/Centro de Pesquisa Clínica e Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
- 700 1_
- $a Coarelli, Giulia $u Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm U1127, CNRS UMR7225, Paris, France $u Department of Genetics, Neurogene National Reference Centre for Rare Diseases, Pitié-Salpêtrière University Hospital, Assistance Publique, Hôpitaux de Paris, Paris, France
- 700 1_
- $a Dankova, Michaela $u Department of Neurology, Centre of Hereditary Ataxias, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Traschütz, Andreas $u Research Division "Translational Genomics of Neurodegenerative Diseases", Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany $u German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany
- 700 1_
- $a Tarnutzer, Alexander A $u Neurology, Cantonal Hospital of Baden, 5404, Baden, Switzerland. alexander.tarnutzer@access.uzh.ch $u Faculty of Medicine, University of Zurich, Zurich, Switzerland. alexander.tarnutzer@access.uzh.ch
- 773 0_
- $w MED00007845 $t Cerebellum $x 1473-4230 $g Roč. 23, č. 3 (2024), s. 896-911
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37117990 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133858 $b ABA008
- 999 __
- $a ok $b bmc $g 2143565 $s 1225692
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 23 $c 3 $d 896-911 $e 20230428 $i 1473-4230 $m Cerebellum $n Cerebellum $x MED00007845
- LZP __
- $a Pubmed-20240725